triptolide has been researched along with Hypertrophy, Left Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Gong, K; Li, R; Lu, K; Shen, H; Wang, Y; Yao, D; Zhang, F; Zhang, Z | 1 |
1 other study(ies) available for triptolide and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression.
Topics: Animals; Anti-Inflammatory Agents; Diterpenes; Down-Regulation; Drugs, Chinese Herbal; Epoxy Compounds; Fibrosis; Heart Ventricles; Hypertrophy, Left Ventricular; Immunity, Innate; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Phenanthrenes; Tripterygium; Ventricular Remodeling | 2017 |